VI HTA Symposium in Krakow – Confirmed Speakers and Preliminary Program

Arcana Institute is hosting its annual HTA Symposium in Krakow, bringing together recognized experts from public and private sectors to discuss current events and challenges taking place in Poland in the context of HTA. This year’s Symposium is organized by Arcana Institute with the cooperation of Technomed and ThinkTank and will take place on June 11-12, 2018 at the Manggha Museum of Japanese Art and Technology.

Confirmed Speakers

Marcin Czech – Undersecretary of State at the Polish Ministry of Health
Zbigniew Król – Undersecretary of State at the Polish Ministry of Health
Krzysztof ŁandaConsultant, Dentons. Former Deputy Minister at the Polish Ministry of Health
Roman Topór-Mądry – President of the Agency for Health Technology Assessment in Poland (AHTAPol)
Iga Lipska – Director of Drug Policy and Pharmacy Department at the Polish Ministry of Health
Ewa WarmińskaSenior Associate, Dentons. Former Deputy Director of Drug Policy Department at MoH
Maciej BanachPresident of Polish Mother’s Memorial Hospital – Research Institute
Małgorzata Gałązka-SobotkaDirector of Lazarski University Centre for Postgraduate Studies
Paweł GrzesiowskiPresident of Foundation Institute for Prevention of Infections
Waldemar StyloDirector of the District Hospital in Chrzanow

Preliminary Program

Below are sessions by day with planned topics to be addressed by our speakers

June 11

Session I: Important Changes and Challenges

  • Overview of the impact of major legal changes and an update of new/planned changes
  • Risk Sharing Schemes (RSS) based on health outcomes
  • Existing databases within Poland’s National Health Fund (NFZ) and their potential uses
  • Joint drug price negotiation in the EU: From the perspective of the V4 group
  • Access to modern health techonologies

Session II: HTA in Europe

  • EU-level cooperation on HTA
  • European Commission’s proposal for a regulation to the European Parliment and the Council on HTA: From the perspective of Poland and the V4 group
  • EU-level clinical assessment – opportunity or threat to medical devices
  • EUnetHTA assessments and reimbursement in Poland – Feasibility study of joint clinical assessment
  • HTA Master File (Core Mock HTA) – possible uses in face of planned changes

Session III: Health Innovation

Our partner for this session is ThinkTank

  • Role of government for driving health innovation
  • Programs such as the National Centre for Research and Development in Poland for financing of innovation
  • Is cooperation between public hospitals and private businesses effective for creating innovation in healthcare?
  • Criteria for assessing innovation from the investor’s perspective
  • Alternative approaches to financing of innovative therapies

June 12

Session I: The Modern Hospital

  • Payment models for driving innovation in oncology, an example of the Center for Oncology
  • Are hospitals ready for innovation?
  • New financing models for treatment in hospitals as a way for creating innovation
  • Assessing hospital network operations – a district hospital director’s perspective
  • Implications of central purchasing of drugs and medical devices in hospitals
  • Changes in purchasing policy of medical devices – how to achieve efficient use of resources in healthcare facilities

Session II: Non-Drug Technologies in Healthcare

  • Implementation of E-Health into the healthcare system
  • The most important changes concerning Medical Devices
  • Benefit package – current financing model vs. the introduction of new health technologies
  • Telemedicine as a tool for resource and outcomes optimization. Finding its place within the financing from public funds.
  • Value-based approach to financing of new non-drug technologies and telemedicine
The speaker and discussion panels during the Symposium will be held in Polish language.
If you are interested in registering for the Symposium or would like to receive more information, please send an e-mail to or call +48 669 322 632
VI HTA Symposium in Krakow – Confirmed Speakers and Preliminary Program